Highlights Histogen Inc.

Equities

HSTO

US43358Y2028

Market Closed - OTC Markets Other stock markets 02:11:58 2024-04-29 pm EDT			5-day change	1st Jan Change
0.3511 ^USD	+0.03%		+0.29%	+14.10%

Apr. 19	Subchapter V Trustee Appointed Under Chapter 11 for Histogen Inc.	CI
Apr. 18	Histogen Inc. Filed for Bankruptcy	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Histogen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Histogen Inc. and Allergan Mutually Elect to Terminate the Amended and Restated License Agreement	23-10-03	CI
Histogen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Histogen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University	23-04-03	CI
Histogen Gets US Patent Offering Broad Coverage for Anti-Inflammatory Caspase Inhibitors; Shares Rise Pre-Bell Friday	23-03-17	MT
Histogen Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-09	CI
Histogen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Histogen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Earnings Flash (HSTO) HISTOGEN Reports Q2 Revenue $5,000	22-08-11	MT
Earnings Flash (HSTO) HISTOGEN Reports Q1 Revenue $3.8M	22-05-12	MT
Histogen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Histogen Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-10	CI
Histogen Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-03-10	CI
Histogen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Earnings Flash (HSTO) HISTOGEN Reports Q3 Revenue $591,000	21-11-10	MT
Histogen Inc. and Amerimmune, LLC Announces Additional Findings from Its Phase 1 Study of Emricasan in Mild Symptomatic Covid-19 Patients	21-08-16	CI
Histogen : Earnings Flash (HSTO) HISTOGEN Reports Q2 Revenue $5,000	21-08-11	MT
Histogen Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2021	21-08-11	CI
Histogen Announces Initiation of HST 003 Phase 1/2 Trial for Knee Cartilage Regeneration	21-06-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Histogen Inc.

Equities

HSTO

US43358Y2028

Highlights

Filters